Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke
Stroke - United States
doi 10.1161/strokeaha.115.009854
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)